COVID-19 Response: Local Logistics     National Effort       

A Microfluidic-based Flow Analyzer

You are here

COVID-19 Response: Local Logistics     National Effort

The Novel Technology:

The invention discloses a microfluidic flow analyzer. In particular, the technology is an evaluative technology for various diseases primarily for immune response monitoring through CD4/CD8 cell counting in HIV/AIDS at point-of-care locations. 
 
Applications:
  • To use in AIDS health monitoring
  • To use in cell culture assays
  • To use in detection of water contamination
  • To use blood cell count, stem cells, oncological tests, etc
Advantages:
  • Lower device cost
  • Lower sample running cost
  • Higher portability for non-conventional environments
  • Ability to run the device on battery power
  • Volume of samples required is low
  • Minimal technical knowledge required to use the device
  • Ease of maintenance
  • Ease of modification and upgradability
Business Model:
 
The technology is at an early stage of development. A basic proof-of-concept has been developed. The technology is now being tested on human cells. Currently looking for industrial partners to take the technology further and commercialize.  
 
Principal Investigator(s): Taslimarif Saiyed, Anil Prabhakar, Sudip Mondal, H Krishnamurthy
 
Invention ID: CMP-015
 
IP Status: Granted  - US patent no. US 9,304,122, South Africa patent no. 2014/06473, China patent no. 0010282.7, Japan patent no. 6138163, Eurasia patent no. 1411403/22EA
 
Jurisdictions: India (IN), United States (US), Europe (EP), China (CN), Korea (KR), Japan (JP), Nigeria (NG), Vietnam (VN), South Africa (ZA), Eurasia, ARIPO
 
For more details, please write to: 
techtransfer @ccamp.res.in